🧠 CJC-1295 with DAC Research Protocol

ChemAesthetic | For research use only
5mg lyophilized peptide vial

⸻

🔬 Compound Overview

CJC-1295 with DAC is a long-acting GHRH (Growth Hormone Releasing Hormone) analogue that has been studied for its ability to prolong GH secretion in laboratory models.

The DAC (Drug Affinity Complex) component allows CJC-1295 to bind to albumin, significantly extending its half-life and stability in circulation.

Research has focused on its potential to modulate:
• Growth hormone (GH) and IGF-1 release
• Sleep-associated GH pulses
• Body composition and recovery-related signaling pathways

Its prolonged action has made it a compound of interest in comparative studies on pulsatile vs. sustained GH stimulation models.

⸻

💧 Reconstitution Instructions

Reconstitute with sterile bacteriostatic water.
Swirl gently — do not shake.

Vial Strength: 5mg vial
BAC Water Volume: 1ml
Final Concentration: 0.5mg per 0.1ml (10 units)

Using a 100-unit insulin syringe:
* 10 units = 0.5mg
* 20 units = 1mg

⸻

📏 Dosing Guidelines (For Research Use Only)

• Common research protocols range: 1–2mg per injection
• Frequency: 1–2 times per week, due to extended half-life
• Administered subcutaneously in GH pathway studies
• Wipe vial stopper with alcohol before each use

DAC-based protocols differ from standard CJC-1295 or Mod GRF (1-29) and require less frequent administration.

⸻

🧊 Storage

• Store reconstituted peptide refrigerated (2–8°C)
• Use within 60 days
• Keep sealed and away from light

⸻

📎 Legal & Research Notice

• Provided strictly for laboratory research
• Not for human or veterinary consumption